Literature DB >> 22649047

Toward absolute quantification of iron oxide nanoparticles as well as cell internalized fraction using multiparametric MRI.

O M Girard1, R Ramirez, S McCarty, R F Mattrey.   

Abstract

Iron oxide nanoparticles (IONPs) are widely used as MR contrast agents because of their strong magnetic properties and broad range of applications. The contrast induced by IONPs typically depends on concentration, water accessibility, particle size and heterogeneity of IONP distribution within the microenvironment. Although the latter could be a tool to assess local physiological effects at the molecular level, it renders IONP quantification from relaxation measurements challenging. This study aims to quantify IONP concentration using susceptibility measurements. In addition, further analysis of relaxation data is proposed to extract quantitative information about the IONP spatial distribution. Mesenchymal stem cells were labeled with IONPs and the IONP concentration measured by mass spectroscopy. MR relaxation parameters (T(1), T(2), T(2)*) as well as magnetic susceptibility of cylindrical samples containing serial dilutions of mixtures of free and cell-internalized IONPs were measured and correlated with IONP concentration. Unlike relaxation data, magnetic susceptibility was independent of whether IONPs were free or internalized, making it an excellent candidate for IONP quantification. Using IONP concentration derived from mass spectroscopy and measured relaxation times, free and internalized IONP fractions were accurately calculated. Magnetic susceptibility was shown to be a robust technique to measure IONP concentration in this preliminary study. Novel imaging-based susceptibility mapping techniques could prove to be valuable tools to quantify IONP concentration directly by MRI, for samples of arbitrary shape. Combined with relaxation time mapping techniques, especially T(2) and T(2)*, this could be an efficient way to measure both IONP concentration and the internalized IONP fraction in vivo using MRI, to gain insight into tissue function and molecular imaging paradigms.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22649047      PMCID: PMC3383460          DOI: 10.1002/cmmi.1467

Source DB:  PubMed          Journal:  Contrast Media Mol Imaging        ISSN: 1555-4309            Impact factor:   3.161


  28 in total

1.  Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnetic field.

Authors:  Ludovic de Rochefort; Ryan Brown; Martin R Prince; Yi Wang
Journal:  Magn Reson Med       Date:  2008-10       Impact factor: 4.668

2.  T2 relaxation induced by clusters of superparamagnetic nanoparticles: Monte Carlo simulations.

Authors:  Yuri Matsumoto; Alan Jasanoff
Journal:  Magn Reson Imaging       Date:  2008-05-13       Impact factor: 2.546

3.  Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging.

Authors:  Ludovic de Rochefort; Tian Liu; Bryan Kressler; Jing Liu; Pascal Spincemaille; Vincent Lebon; Jianlin Wu; Yi Wang
Journal:  Magn Reson Med       Date:  2010-01       Impact factor: 4.668

Review 4.  Activatable T₁ and T₂ magnetic resonance imaging contrast agents.

Authors:  Chuqiao Tu; Elizabeth A Osborne; Angelique Y Louie
Journal:  Ann Biomed Eng       Date:  2011-02-18       Impact factor: 3.934

5.  Validation of oxygen extraction fraction measurement by qBOLD technique.

Authors:  Xiang He; Mingming Zhu; Dmitriy A Yablonskiy
Journal:  Magn Reson Med       Date:  2008-10       Impact factor: 4.668

Review 6.  Detection and quantification of magnetically labeled cells by cellular MRI.

Authors:  Wei Liu; Joseph A Frank
Journal:  Eur J Radiol       Date:  2008-11-07       Impact factor: 3.528

Review 7.  In vivo MRI cell tracking: clinical studies.

Authors:  Jeff W M Bulte
Journal:  AJR Am J Roentgenol       Date:  2009-08       Impact factor: 3.959

8.  In vivo MRI using positive-contrast techniques in detection of cells labeled with superparamagnetic iron oxide nanoparticles.

Authors:  Wei Liu; Hannes Dahnke; E Kay Jordan; Tobias Schaeffter; Joseph A Frank
Journal:  NMR Biomed       Date:  2008-03       Impact factor: 4.044

9.  In vivo single cell detection of tumor-infiltrating lymphocytes with a clinical 1.5 Tesla MRI system.

Authors:  Pierre Smirnov; Marie Poirier-Quinot; Claire Wilhelm; Elise Lavergne; Jean-Christophe Ginefri; Béhazine Combadière; Olivier Clément; Luc Darrasse; Florence Gazeau
Journal:  Magn Reson Med       Date:  2008-12       Impact factor: 4.668

10.  R2 and R2* mapping for sensing cell-bound superparamagnetic nanoparticles: in vitro and murine in vivo testing.

Authors:  Rebecca Kuhlpeter; Hannes Dahnke; Lars Matuszewski; Thorsten Persigehl; Angelika von Wallbrunn; Thomas Allkemper; Walter L Heindel; Tobias Schaeffter; Christoph Bremer
Journal:  Radiology       Date:  2007-09-11       Impact factor: 11.105

View more
  20 in total

1.  Quantification of Macrophages in High-Grade Gliomas by Using Ferumoxytol-enhanced MRI: A Pilot Study.

Authors:  Michael Iv; Peyman Samghabadi; Samantha Holdsworth; Andrew Gentles; Paymon Rezaii; Griffith Harsh; Gordon Li; Reena Thomas; Michael Moseley; Heike E Daldrup-Link; Hannes Vogel; Max Wintermark; Samuel Cheshier; Kristen W Yeom
Journal:  Radiology       Date:  2018-11-06       Impact factor: 11.105

2.  Simultaneous quantitative susceptibility mapping (QSM) and R2* for high iron concentration quantification with 3D ultrashort echo time sequences: An echo dependence study.

Authors:  Xing Lu; Yajun Ma; Eric Y Chang; Qun He; Adam Searleman; Annette von Drygalski; Jiang Du
Journal:  Magn Reson Med       Date:  2018-01-04       Impact factor: 4.668

3.  Zero echo time magnetic resonance imaging of contrast-agent-enhanced calcium phosphate bone defect fillers.

Authors:  Yi Sun; Manuela Ventura; Egbert Oosterwijk; John A Jansen; X Frank Walboomers; Arend Heerschap
Journal:  Tissue Eng Part C Methods       Date:  2013-01-18       Impact factor: 3.056

4.  Small magnetite antiretroviral therapeutic nanoparticle probes for MRI of drug biodistribution.

Authors:  Dongwei Guo; Tianyuzi Li; JoEllyn McMillan; Balasrinivasa R Sajja; Pavan Puligujja; Michael D Boska; Howard E Gendelman; Xin-Ming Liu
Journal:  Nanomedicine (Lond)       Date:  2013-08-01       Impact factor: 5.307

5.  Establishing the overlap of IONP quantification with echo and echoless MR relaxation mapping.

Authors:  Hattie L Ring; Jinjin Zhang; Nathan D Klein; Lynn E Eberly; Christy L Haynes; Michael Garwood
Journal:  Magn Reson Med       Date:  2017-06-26       Impact factor: 4.668

6.  Quantification and biodistribution of iron oxide nanoparticles in the primary clearance organs of mice using T1 contrast for heating.

Authors:  Jinjin Zhang; Hattie L Ring; Katie R Hurley; Qi Shao; Cathy S Carlson; Djaudat Idiyatullin; Navid Manuchehrabadi; P Jack Hoopes; Christy L Haynes; John C Bischof; Michael Garwood
Journal:  Magn Reson Med       Date:  2016-09-25       Impact factor: 4.668

7.  Magnetic resonance imaging contrast of iron oxide nanoparticles developed for hyperthermia is dominated by iron content.

Authors:  Michele Wabler; Wenlian Zhu; Mohammad Hedayati; Anilchandra Attaluri; Haoming Zhou; Jana Mihalic; Alison Geyh; Theodore L DeWeese; Robert Ivkov; Dmitri Artemov
Journal:  Int J Hyperthermia       Date:  2014-05       Impact factor: 3.914

8.  Dual contrast agent for computed tomography and magnetic resonance hard tissue imaging.

Authors:  Manuela Ventura; Yi Sun; Viorel Rusu; Peter Laverman; Paul Borm; Arend Heerschap; Egbert Oosterwijk; Otto C Boerman; John A Jansen; X Frank Walboomers
Journal:  Tissue Eng Part C Methods       Date:  2012-12-21       Impact factor: 3.056

Review 9.  Nanoparticles and clinically applicable cell tracking.

Authors:  Monique R Bernsen; Jamal Guenoun; Sandra T van Tiel; Gabriel P Krestin
Journal:  Br J Radiol       Date:  2015-08-07       Impact factor: 3.629

10.  Ultrashort echo time for improved positive-contrast manganese-enhanced MRI of cancer.

Authors:  Joris Tchouala Nofiele; Hai-Ling Margaret Cheng
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.